These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 19776224

  • 1. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset.
    Sanner H, Gran JT, Sjaastad I, Flatø B.
    Rheumatology (Oxford); 2009 Dec; 48(12):1541-7. PubMed ID: 19776224
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study.
    Mathiesen P, Hegaard H, Herlin T, Zak M, Pedersen FK, Nielsen S.
    Scand J Rheumatol; 2012 Feb; 41(1):50-8. PubMed ID: 22044089
    [Abstract] [Full Text] [Related]

  • 3. Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool.
    Sanner H, Sjaastad I, Flatø B.
    Rheumatology (Oxford); 2014 Sep; 53(9):1578-85. PubMed ID: 24692575
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients.
    Mathiesen PR, Buchvald F, Nielsen KG, Herlin T, Friis T, Nielsen S.
    Rheumatology (Oxford); 2014 Apr; 53(4):644-9. PubMed ID: 24310298
    [Abstract] [Full Text] [Related]

  • 6. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.
    Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P, MacNeil I, Momy JA, Avery G, Feldman BM.
    Arthritis Rheum; 2000 Mar; 43(3):541-9. PubMed ID: 10728746
    [Abstract] [Full Text] [Related]

  • 7. In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity.
    Schwartz T, Sanner H, Gjesdal O, Flatø B, Sjaastad I.
    Ann Rheum Dis; 2014 Oct; 73(10):1805-10. PubMed ID: 23881732
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage.
    Sanner H, Schwartz T, Flatø B, Vistnes M, Christensen G, Sjaastad I.
    PLoS One; 2014 Oct; 9(3):e92171. PubMed ID: 24647150
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study.
    Apaz MT, Saad-Magalhães C, Pistorio A, Ravelli A, de Oliveira Sato J, Marcantoni MB, Meiorin S, Filocamo G, Pilkington C, Maillard S, Al-Mayouf S, Prahalad S, Fasth A, Joos R, Schikler K, Mozolova D, Landgraf JM, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation.
    Arthritis Rheum; 2009 Apr 15; 61(4):509-17. PubMed ID: 19333974
    [Abstract] [Full Text] [Related]

  • 17. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.
    Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A, Paediatric Rheumatology International Trials Organization (PRINTO), Pediatric Rheumatology Collaborative Study Group (PRCSG).
    Rheumatology (Oxford); 2003 Dec 15; 42(12):1452-9. PubMed ID: 12832713
    [Abstract] [Full Text] [Related]

  • 18. Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset.
    Manlhiot C, Liang L, Tran D, Bitnun A, Tyrrell PN, Feldman BM.
    Rheumatology (Oxford); 2008 Apr 15; 47(4):526-9. PubMed ID: 18304939
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years.
    Flatø B, Lien G, Smerdel A, Vinje O, Dale K, Johnston V, Sørskaar D, Moum T, Ploski R, Førre Ø.
    J Rheumatol; 2003 Feb 15; 30(2):386-93. PubMed ID: 12563700
    [Abstract] [Full Text] [Related]

  • 20. Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients.
    Mathiesen PR, Zak M, Herlin T, Nielsen SM.
    Clin Exp Rheumatol; 2010 Feb 15; 28(5):782-9. PubMed ID: 21029565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.